Tag Archive: Hybrid Inspections

Revolutionizing Drug Manufacturing: A closer look at pending Facility Applications for GMP Inspections

November 10, 2023 || Connie Leech and Geraldine Carr-Mulry
 
COVID-19 pandemic exposed vulnerabilities and challenges in pharmaceutical supply chains, leading to drug shortages and disruptions. Whilst certain aspects of the pandemic have gone away, drug shortages have persisted on a global scale. The demand for flexibility in the supply chain remains imperative, However, many drug manufacturers are still reluctant…
Read More